It's hard to believe that any one person could “head” this agency effectively, much less someone with no administrative experience or medical training.

RFK Jr. would also have the power, along with the FDA commissioner, to slow down or hamper the process by which new vaccines are evaluated, approved, and recommended. That could discourage pharmaceutical companies from developing new or reformulated vaccines.